• All
  • Important
  • Financial Update
  • Fund Raise
  • Board Meeting
  • Dividend/Bonus
  • JV/Acquisition
  • Investor Meet
  • Insider Trade
  • Pledging
  • Others
    ALPHA TRIBE

    Ajanta Pharma Limited — Board Meeting, 03-11-2025: Outcome of Board Meeting

    03-11-2025 | 01:32 pm

    Ajanta Pharma's Board approved Q2 & H1 FY26 consolidated results. Q2 PAT jumped 20% to Rs 260 Cr, with revenue up 14%. H1 PAT grew 12% to Rs 516 Cr. A Rs 28/share interim dividend (total Rs 350 Cr) was declared. US Generics sales surged 42% in H1.

    No comments yet. Be the first to comment!

    All announcements from Ajanta Pharma Limited